Patent Notice
Patent Notice
In accordance with 35 U.S.C. § 287(a), the following table may be used to determine U.S. patent numbers associated with the corresponding product marketed in the U.S. The table is subject to change and may not list all patents associated with the listed products. Meitheal owns or has exclusive licenses to additional U.S. and foreign patents and pending applications that may be associated with the listed products or other Meitheal products.
Product
Associated Patent(s)
CONTEPO™ (fosfomycin disodium) for Injection
U.S. 9,345,717; U.S. 10,086,006; U.S. 11,541,064
XENLETA® (lefamulin acetate) Injection and Tablets
U.S. 8,071,643; U.S. 8,153,689; U.S. 9,120,727; U....
You might also be interested
The brands mentioned here are the trademarks of their respective owners.